Sally Jackson - GSK Plc VP Office
| G1SK34 Stock | BRL 40.44 0.84 2.12% |
Insider
Sally Jackson is VP Office of GSK plc
| Phone | 44 20 8047 5000 |
| Web | https://www.gsk.com |
GSK Plc Management Efficiency
The company has return on total asset (ROA) of 0.0659 % which means that it generated a profit of $0.0659 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3131 %, meaning that it generated $0.3131 on every $100 dollars invested by stockholders. GSK Plc's management efficiency ratios could be used to measure how well GSK Plc manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Tiffany McGowen | Paycom Software | N/A | |
| Richard Esq | Dell Technologies | 59 | |
| Michael Dell | Dell Technologies | 58 | |
| Chad Richison | Paycom Software | 53 | |
| Jennifer Saavedra | Dell Technologies | 53 | |
| Holly Faurot | Paycom Software | 38 | |
| Michael Zimmerman | Dell Technologies | N/A | |
| Allison Dew | Dell Technologies | 53 | |
| Justin Long | Paycom Software | 45 | |
| James Samford | Paycom Software | N/A | |
| Rafael Gorenstein | Lupatech SA | N/A | |
| Anthony Whitten | Dell Technologies | 47 | |
| Kristy Ross | Paycom Software | N/A | |
| Paulo Silva | Lupatech SA | N/A | |
| Craig Boelte | Paycom Software | 60 | |
| William Scannell | Dell Technologies | 61 | |
| Thomas Sweet | Dell Technologies | 63 | |
| Matthew Paque | Paycom Software | N/A | |
| Jeffrey Clarke | Dell Technologies | 60 | |
| Bradley Smith | Paycom Software | 53 | |
| Brunilda Rios | Dell Technologies | 57 | |
Management Performance
| Return On Equity | 0.31 | |||
| Return On Asset | 0.0659 |
GSK plc Leadership Team
Elected by the shareholders, the GSK Plc's board of directors comprises two types of representatives: GSK Plc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GSK. The board's role is to monitor GSK Plc's management team and ensure that shareholders' interests are well served. GSK Plc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GSK Plc's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Redfern, Chief Officer | ||
| Diana Conrad, Chief Officer | ||
| Emma Walmsley, CEO Director | ||
| Sally Jackson, VP Office | ||
| Iain Mackay, CFO Director | ||
| James Ford, Sr Compliance | ||
| Shobie Ramakrishnan, Chief Officer | ||
| Sarah EltonFarr, Head Relations | ||
| Julie Brown, Chief Officer | ||
| Tony Wood, Chief Officer |
GSK Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is GSK Plc a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.31 | |||
| Return On Asset | 0.0659 | |||
| Profit Margin | 0.51 % | |||
| Operating Margin | 0.25 % | |||
| Current Valuation | 484.56 B | |||
| Shares Outstanding | 4.09 B | |||
| Price To Book | 2.60 X | |||
| Price To Sales | 9.93 X | |||
| Revenue | 34.11 B | |||
| Gross Profit | 19.92 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in GSK Stock
GSK Plc financial ratios help investors to determine whether GSK Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GSK with respect to the benefits of owning GSK Plc security.